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The measurement of changes in nicotinic acid adenine dinucleotide phosphate (NAADP) levels in cells has been, and remains, key to
the investigation of the functions of NAADP as a Ca2+-releasing second messenger. Here we provide details of how to isolate NAADP
from cells by extraction with perchloric acid and then measure the NAADP using a radioreceptor assay. We demonstrate that NAADP is
neither generated nor broken down during sample processing conditions and that radioreceptor assay is highly selective for the detection
of NAADP under cell extract conditions. Furthermore, a number of improvements, such as solid-state detection of the radioactivity, are
incorporated to enhance the safety of the procedure. Finally, we have developed a new method to prevent the endogenous metabolism of
NAADP by chelating Ca2+ with bis-(o-aminophenoxy)ethane-N,N,N 0,N 0-tetraacetic acid (BAPTA), thereby reducing the diﬃculty of
catching a small transient rise in NAADP levels. In summary, we have reﬁned and improved a method for measuring NAADP levels
and presented it in a manner accessible to a wide range of laboratories. It is expected that this will enhance research in the NAADP ﬁeld.
 2007 Elsevier Inc.
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Open access under CC BY license.The cytosolic concentration of Ca2+ is very closely regu-
lated in cells; the resting concentration usually is maintained
at approximately 10–7 M. Changes in Ca2+ concentration
play an important role in a wide range of processes—from
fertilization, to the regulation of cell function throughout
life, to cell death [1]. This resting concentration may be
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Open access under CC BY license.matrix through a channel in the plasma membrane or
release of Ca2+ from intracellular stores. Release of Ca2+
from intracellular stores usually is a result of the binding
of a primary messenger, such as a hormone or neurotrans-
mitter, to a receptor in the plasma membrane. This in turn
results in the generation of a second messenger inside the
cell that is able to release Ca2+ from an intracellular store.
The best-characterized Ca2+-releasing second messenger is
d-myo-inositol 1,4,5-trisphosphate (IP3).
6 It is synthesized6 Abbreviations used: IP3, D-myo-inositol 1,4,5-trisphosphate; NAADP,
nicotinic acid adenine dinucleotide phosphate; cADPR, cyclic ADP
ribose; NAD, nicotinamide adenine dinucleotide; NADP, nicotinamide
adenine dinucleotide phosphate; HPLC, high-performance liquid chro-
matography; TFA, triﬂuoroacetic acid; NADPH, reduced-form NADP;
ASW, artiﬁcial sea water; BAPTA-AM, 1,2-bis(2-aminophenoxy)ethane-
N,N,N0,N0-tetraacetic acid tetrakis (acetoxymethyl) ester; CCK, cholecys-
tokinin; NADH, reduced-form NAD; NAAD, nicotinic acid adenine
dinucleotide.
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which in turn activates phospholipase C to cleave IP3 from
phosphatidylinositol 4,5-bisphosphate. IP3 binds to the IP3
receptor in the endoplasmic reticulum membrane and
releases Ca2+ from the endoplasmic reticulum [2].
Nicotinic acid adenine dinucleotide phosphate
(NAADP) was ﬁrst reported as a Ca2+-releasing agent in
1995 [3]. However, in contrast to IP3, very little is known
about the physiological roles of NAADP. The site of action
of NAADP remains controversial; there is evidence to sug-
gest that NAADP releases from an acidic lysosome-like
store [4,5], although there are also reports of it aﬀecting
ryanodine receptors on the endoplasmic reticulum [6].
NAADP has now been categorized as a second messenger,
according to the conditions laid down by Sutherland and
coworkers [7], in both the sea urchin [8] and model mam-
malian [9] systems. The ability to measure changes in
NAADP levels in cells has been key to this categorization,
providing evidence that NAADP is synthesized in response
to the binding of an agonist to its cell surface receptor. This
remains very important in characterizing NAADP in a
wider range of cell types, enabling a more comprehensive
picture of the functions of NAADP as a second messenger
to be built up. Basal NAADP levels have been measured in
a variety of sea urchin [10], plant [11], and mammalian
[12,13] cell types. Only recently, however, have agonist-
induced changes in NAADP levels been reported in sea
urchin sperm [8], pancreatic beta cells [9], smooth muscle
cells [14], pancreatic acinar cells [15], and T cells [13]. The
majority of these measurements have been made using a
radioreceptor binding assay [12], although a cycling assay
[13,16,17] has also been described.
In theory, it is possible to use a bioassay in sea urchin
egg homogenate, similar to that used for cyclic ADP ribose
(cADPR) [18], to detect NAADP. However, there are no
reports of NAADP measurements using such a technique.
Three variations on a cycling assay have been reported
[13,16,17]. These assays oﬀer sensitive detection of
NAADP, with 50-fmol quantities being detectable with
one method [13], and have the beneﬁt that they do not
require the preparation of a radioligand. However, the pro-
cessing of samples is technically demanding and time-con-
suming. Cell extracts require puriﬁcation by anion
exchange chromatography and subsequent enzyme treat-
ment prior to determination of the NAADP concentration,
which is actually determined indirectly from the resulting
concentration of nicotinamide adenine dinucleotide
(NAD) or nicotinamide adenine dinucleotide phosphate
(NADP). The radioreceptor binding assay that we report
here is capable of directly detecting 100-amol quantities
of NAADP without the risk of interference from other
compounds. Furthermore, it is possible to quickly process
a large number of samples prepared using a straightfor-
ward acid extraction technique without the need for further
puriﬁcation.
Previously expressed concerns encompassing the genera-
tion or degradation of NAADP, as well as the selectivity ofthe assay, and the recovery of NAADP in a cell extract are
addressed in detail. Importantly, we report a new method
where NAADP increases are measured as NAADP accu-
mulation over time. In summary, we have reﬁned and val-
idated a powerful method for measuring NAADP levels,
and we present it in an accessible manner that will enable
even inexperienced researchers to measure NAADP levels.
The importance of these measurements at this stage in our
understanding of the functions of NAADP cannot be over-
looked. It is expected that this will enhance research in the
NAADP ﬁeld.Materials and methods
Materials
All chemicals were purchased from Sigma (UK) except
where otherwise indicated below.High-performance liquid chromatography
All high-performance liquid chromatography (HPLC)
was carried out on an anion exchange resin (AGMP1,
Bio-Rad, USA), packed in 150 · 2.5-mm Omniﬁt columns,
using a concave upward gradient of triﬂuoroacetic acid
(TFA), delivered by a Waters 600e pump, as described pre-
viously [19]. Detection was performed by a UV detector
(Waters 2487, UK) at 254 nm.Stability of nucleotides under diﬀerent pH conditions
NADP, NAADP, or NADPH (reduced-form NADP) (1
mM) was incubated in the following buﬀers for 6 h: 50 mM
Hepes (pH 7.2), 0.75 M HClO4 (pH 0.88), 1 M KHCO3
(pH 9.1), 0.75 M HClO4/1 M KHCO3 (pH 8.6), or 1 M
K2CO3 (pH 11). Samples were then neutralized with their
base equivalence of either Tris base (for acidic solutions)
or Hepes acid (for basic solutions) as applicable. Samples
were analyzed by HPLC as described above, with elution
times being determined from standard runs with known
compounds.Acid extraction of NAADP
Cells may be prepared in any suitable manner; gametes,
isolated cells, chopped tissue, and cells in culture all have
been used successfully. Cells were then exposed to agonist,
and at the appropriate time points the reaction in cells was
stopped by the addition of 0.75 M ice-cold HClO4 added as
an equal volume of 1.5 M solution. Sonication (Jencons
Vibracell at amplitude 60) was carried out to disrupt the
cells, which were then placed on ice for 15 min. The dena-
tured protein was pelleted by centrifugation at 9000g for 10
min and stored at –80 C for later analysis. Supernatant
was neutralized with 1 M KHCO3, added as an equal vol-
ume of 2 M solution, and vortexed. The resulting KClO4
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min. Samples were stored at –80 C for later analysis.
Determination of percentage recovery of NAADP by acid
extraction
Lytechinus pictus (sea urchins) were given intracoelomic
injections of 1 ml of 0.5 M KCl. Eggs were harvested into
artiﬁcial sea water (ASW) with the following composition:
435 mM NaCl, 15 mM MgSO4, 11 mM CaCl2, 10 mM
KCl, 2.5 mM NaHCO3, and 20 mM Tris–Cl (pH 8.0).
Sperm was collected ‘‘dry’’ on a Petri dish. Samples con-
sisted of 20 ll sperm and 80 ll eggs in ASW. The samples
were spiked with [32P]NAADP and then processed as
described later. The resulting solution was then counted,
and the total percentage recovery was determined.
Isolation and use of pancreatic acinar cells
Pancreatic acinar cells were prepared as described previ-
ously [15]. Brieﬂy, pancreata were excised from 8- to 10-
week-old male CD1 mice and were ﬁnely chopped before
incubation with 200 U/ml collagenase for 15 min at 37
C. The digested tissue was then washed and resuspended
to 10 ml with buﬀer of the following composition: 140
mM NaCl, 4.7 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10
mM Hepes, and 10 mM glucose (pH 7.4). Protease inhibi-
tor cocktail tablets (EDTA free, Roche Diagnostics, UK),
one tablet per 50 ml, were added to this solution before use.
The suspension was triturated, and supernatant that con-
tained dispersed cells was collected into a new tube. After
centrifugation at 800g for 3 min at 4 C, the supernatant
was discarded and the cell pellet was resuspended for fur-
ther trituration and centrifugation. The resulting superna-
tant was discarded, and the cells were kept in buﬀer
supplemented with 1 mM CaCl2 at room temperature on
a rocking board for 30 min before use. Prior to use, the
cells were centrifuged at 800g for 1 min at 4 C. The cells
were suspended in the above buﬀer without the addition
of protease inhibitors. Pancreatic acinar cells were ali-
quoted into tubes. These aliquots were incubated with 20
lM 1,2-bis(2-aminophenoxy)ethane-N,N,N 0,N 0-tetraacetic
acid tetrakis (acetoxymethyl) ester (BAPTA-AM), a cell-
permeant Ca2+ chelator, for 30 min at room temperature.
Cholecystokinin (CCK), or buﬀer control, was then added
to each aliquot by pipette. Further sample preparation was
carried out as described earlier.
[32P]NAADP synthesis
[32P]NAADP was synthesized in a two-step reaction
as described previously [18,20]. First, [32P]NADP was
synthesized by incubating 25 ll/9.25 MBq [32P]NAD
(GE Healthcare, UK) with 0.5 U/ml human NAD
kinase (formerly kindly provided by Matthias Ziegler,
currently obtained commercially from Alexis, UK), 5
mM MgATP, and 100 mM Hepes (pH 7.4) for 1 h.Then 100 mM nicotinic acid and 1 lg/ml ADP-ribosyl
cyclase (kindly provided by H. C. Lee, University of
Hong Kong) were added to commence the second step,
which was allowed to proceed for 1 h. The resulting
mixture was pumped onto an HPLC column with a
peristaltic pump. Separation was carried out on an
anion exchange resin (AGMP1) using a concave upward
gradient of TFA as described previously [20–23] with
detection using an in-line Geiger counter (Bioscan Flow
Count B-FC-1000, Bioscan, USA) integrated to the sys-
tem using a Waters bus SAT/IN unit. The NAADP
fraction was then collected and stored in 10 mM Tris
at 4 C for use in the assay. The 14-day half-life of
32P limits use of the [32P]NAADP to approximately 6
weeks from synthesis.Sea urchin homogenate preparation
Sea urchin egg homogenate was prepared as described
previously [18]. Brieﬂy, eggs were harvested from L. pictus
by intracoelomic injection of approximately 1 ml of 0.5 M
KCl. Homogenate was then prepared as described previ-
ously by Dargie and coworkers [24]. Brieﬂy, the eggs were
washed several times by centrifugation at 800g in the fol-
lowing solutions: Ca2+-free ASW with EGTA (twice),
Ca2+-free ASW (twice), and ‘‘intracellular medium.’’ The
intracellular medium had the following composition: 250
mM N-methyl-d-glucamine, 250 mM potassium gluconate,
20 mM Hepes, and 1 mM MgCl2 (pH adjusted to 7.2 with
acetic acid). Homogenization was performed in intracellu-
lar medium, to which the following were added with a
Dounce glass tissue homogenizer with a size A pestle: 2
mM ATP, 20 mM phosphocreatine, 20 U/ml creatine phos-
phokinase, 50 lg/ml leupeptin (EDTA-free cocktail), 20
lg/ml aprotinin, and 100 lg/ml soya bean trypsin inhibi-
tor. Cortical granules were removed by centrifugation at
13,000g for 10 s at 4 C. Homogenate was stored in 0.5-
to 1-ml aliquots at –80 C for up to 5 years and were used
immediately after thawing.NAADP binding
NAADP binding protein from sea urchin (L. pictus) egg
homogenate, which is highly selective for NAADP
[20,23,25], was used. First, 25 ll of test sample was added
to each tube. Second, 125 ll of 1% (v/v) sea urchin egg
homogenate in intracellular medium was added and
allowed to incubate for 10 min at 25 C. Finally, 100 ll
of [32P]NAADP diluted into intracellular medium was then
added to generate approximately 50,000 scintillation
counts per tube. The tubes were then incubated at room
temperature for a further 10 min at 25 C. Note that the
order of addition is important to maximize the sensitivity
of the assay [12]. Bound NAADP was then trapped onto
Whatman GF/B ﬁlter papers using a Brandel Cell Har-
vester. Washing was carried out three times using 1 ml of
timed
sample
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Fig. 1. (A) Schematic diagram of the acid extraction process for
NAADP. Sperm or eggs are harvested from L. pictus, or cells are
prepared from male CD1 mouse pancreas. Agonist is incubated with the
cell preparation, and then HClO4 is added to stop the reaction at the
required time point. The sample is then sonicated to disrupt the cells and
is centrifuged to pellet the protein for subsequent assay. The supernatant
is neutralized with an equal volume of 2 M KHCO3, or other bases
where indicated, in preparation for analysis using the radioreceptor
binding assay. (B) Schematic diagram of the NAADP radioreceptor
binding assay. First, known concentrations of NAADP (blue boxes), or
cell extracts, are added, followed by sea urchin egg homogenate (pale
blue shapes) in intracellular medium and a 10-min incubation period.
NAADP binds irreversibly to the receptors in the homogenate.
[32P]NAADP (red boxes) is then added. This binds to the remaining
available receptor sites. Bound NAADP is separated from the mixture
by ﬁltration, and the radioactivity is determined. Sample NAADP
concentrations may be determined from the standard curve. (For
interpretation of the references to color in this ﬁgure legend, the reader
is referred to the Web version of this article.)
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acetate (pH 7.4).
Scintillation counting
Radioactivity was determined by placing the ﬁlter circles
in a scintillation vial containing 10 ml H2O, followed by
Cerenkov scintillation counting.
Storage phosphor detection
Filter papers were wrapped in cling ﬁlm and then placed
in a cassette to expose a storage phosphor screen (GE
Healthcare) for 1 to 4 h. The screen was then scanned using
a Typhoon 9400 scanner (GE Healthcare) at a resolution of
100 lm. The resulting image was then analyzed using
ImageQuant (GE Healthcare).
Results and discussion
Measurement of NAADP levels, both at rest and in
response to agonist stimulation, has been central to the
initial demonstration of NAADP as a Ca2+-releasing sec-
ond messenger. It is now becoming an ever more impor-
tant process as the roles of NAADP are investigated in
more systems and the agonists that are coupled to
increases in NAADP levels are fully deﬁned. The mea-
surement of NAADP in cells may be divided into two
steps. First, the NAADP is isolated from the cells by
means of acid extraction (Fig. 1A). Second, the NAADP
in these samples is measured using the radioreceptor
binding assay (Fig. 1B). In the ﬁrst step, cells are isolated
from the relevant animal; here we have used pancreatic
acinar cells from CD1 mice and sea urchin (L. pictus)
eggs and sperm. They are then exposed to agonist, and
the reaction is stopped at the appropriate time point by
the addition of HClO4. Cultured cells may be used as
an alternative to a freshly prepared cell suspension; in
this case, they should be scraped oﬀ the tissue culture
plate at this stage. Sonication is used to disrupt the cells,
and the protein is then pelleted. The resulting superna-
tant is neutralized with KHCO3 prior to analysis by
the radioreceptor binding assay. Therefore, it is necessary
to establish that this acid extraction is indeed a valid
method for isolation of NAADP from cells and to deter-
mine how much NAADP is recovered using this method.
The radioreceptor binding assay itself is described and
validated in detail. Finally, a number of improvements
to the process are described.
Stability of NAADP during acid extraction process
During the acid extraction process, HClO4 is added to
the cells, producing an acidic pH (0.88), and this solution
is later neutralized, producing an alkaline pH (8.6). There-
fore, it must be conﬁrmed that NAADP is stable under the
conditions used and that no other nucleotides may be con-verted to NAADP under these conditions. It is commonly
stated that in their oxidized form NAD and NADP are sta-
ble in acidic solutions but unstable in alkaline ones [26]. In
contrast, their reduced forms, NADH and NADPH, are
stable in alkaline solutions but unstable in acidic ones
[26]. In addition, alkaline treatment of NADP has been
used to convert it to NAADP [27]. Moreover, Churamani
and coworkers [12] reported that acid extraction using tri-
chloroacetic acid caused conversion of NADP to NAADP.
Therefore, we investigated the eﬀect of our extraction
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NAADP.
NADP, NAADP, and NADPH were incubated for 6 h
in solutions with a range of pH (0.88–11). Where neces-
sary, these solutions were neutralized with their base
equivalence of Hepes acid or Tris base prior to analysis
by anion exchange HPLC (Fig. 2A). NADP, NAADP,
and NADPH remained stable at pH 7.2 (Fig. 2B). How-
ever, at pH 0.88, 8.6 and 9.1 NADPH became unstable,
whereas NADP and NAADP remained stable (Figs. 2C–
E). NADPH broke down to NADP (15 min) and
uncharged products (0–2 min); these would not interfere
with the detection of NAADP and, hence, were not con-
sidered to be a problem. At pH 11, NADPH proved to
be similarly unstable; some conversion of NAADP to
NADP occurred. More worrisome, NADP converted to
a variety of products, including NAADP (25 min)
(Fig. 2F). Therefore, it was decided to thoroughly inves-
tigate the range of pH that might be encountered under
the extraction conditions of the assay, with particular ref-
erence to the possibility of overshooting the intended pH
when neutralizing with base.
Titration of HClO4 with diﬀerent bases
HClO4 is a strong monoprotic acid, and a 0.75 M solu-
tion has a pH of approximately 0.7. There are several
choices of potassium bases that can be used for neutraliza-
tion, producing a precipitate of KHClO4. Given the sensi-
tivity of both NADP and NAADP to alkaline pH, we
investigated a range of these possibilities. Titration of 1.5
M HClO4 with 1 M KOH, which has been reported as a
neutralizing base [28], gave a sharp equivalence point and
resulted in a maximum pH of between 13 and 14 (see Sup-
plementary Fig. 1). The sharp equivalence point makes it
diﬃcult to add precisely the correct amount to neutralize
the solution without inadvertently generating an alkaline
pH. Therefore, this base was considered to be unsuitable
for use in this technique. K2CO3 may also be used for neu-
tralizations. When 1.5 M HClO4 was titrated with 2 M
K2CO3, the equivalence point was broader, but a small
addition of base beyond this still results in overshooting
to a maximum above pH 10 (Supplementary Fig. 1), which
is outside the conﬁrmed range for stability of the nucleo-
tides. Neutralization with KHCO3 also produced a broader
equivalence point (Supplementary Fig. 1). More important,
even a vast excess of KHCO3 resulted in a pH of less than
9. Hence, the nucleotides remain stable even when an
excess concentration of base is added. This allows for
straightforward neutralization; it is possible to be certain
of complete neutralization without the concern of high
pH resulting in instability. Therefore, the conditions we
use, where the cell extract containing 0.75 M HClO4 is neu-
tralized with an equivalent volume of 2 M KHCO3, are jus-
tiﬁed; at no point are conditions produced that induce
breakdown of NAADP or conversion of NADP to
NAADP.Recovery of NAADP during acid extraction
To determine NAADP recovery in our system, we
spiked the samples with known amounts of [32P]NAADP
and then scintillation counted the samples after extraction.
The sample was incubated with 251,100 ± 31,424 cpm, and
the ﬁnal neutralized extract contained 162,140 ± 27,191
cpm, yielding a recovery of 65 ± 3.7%. Experiments with
unlabeled NAADP show that it is stable during acid
extraction and neutralization (see above); therefore, counts
in ﬁnal neutralized sample are likely to be NAADP. Other
groups have reported cADPR recovery of 48% using 3 M
HClO4 [28], 64% using ATP and perchloric acid [29], and
95% using perchloric acid as judged by immunoreactivity
[30].
Synthesis of [32P]NAADP
Prior to commencement of the radioreceptor binding
assay itself, the appropriate radioligand must be prepared.
We routinely synthesize high-speciﬁc activity [32P]NAADP
using a variation of the procedure ﬁrst reported by Aarhus
and coworkers [19]. We have modiﬁed the reactions and
now commonly get total yields of at least 95% based on
total radioactivity.
In the ﬁrst step of the reaction, the substrates are NAD
and ATP. After incubation for 1 h with human NAD
kinase, all of the NAD is converted to NADP and an
equimolar amount of ATP is converted to ADP
(Fig. 3A). Without purifying any intermediates, the reac-
tion is acidiﬁed by the addition of nicotinic acid (pH 4) to
a ﬁnal concentration of 100 mM, and Aplysia ADP-ribo-
syl cyclase is added to a ﬁnal concentration of 0.1 lg/ml
to exchange the nicotinamide for nicotinic acid. After a 1-
h incubation, there is complete conversion of the NADP
to NAADP (Fig. 3A). Note that the presence of a high
amount of nicotinic acid during the HPLC separation
alters the elution times of the compounds slightly. This
sequence of reactions should be completed each time to
conﬁrm enzyme activity.
For the synthesis of radiolabeled NAADP, the entire
sequence of reactions is repeated but with smaller volumes.
An important consideration was that the human NAD
kinase has a high Km for NAD (0.8 mM) [26]. Therefore,
the volume of the [32P]NAD-containing reaction must be
minimized to keep the NAD concentration as high as pos-
sible. Sea urchin NAD kinase has been used in the past
[20], but it must be freshly isolated. Sea urchin egg homog-
enates, without puriﬁcation, have been used (data not
shown), but both NAD and ATP are metabolized, greatly
limiting the eﬃciency of conversion and the ﬁnal yield.
Human NAD kinase [26] is currently our preferred choice
due to the reproducibility and availability. However, judi-
cious choice of substrate concentrations must be made;
for example, too much ATP will compete with NAD at
its binding site and prevent the reaction. We optimized this
conversion by keeping volumes low to maintain a high
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competitive displacement curve was generated using standard concentra-
tions of NAADP (black ﬁlled circles). Dilutions of the pancreatic acinar
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centration of ATP (5 mM).
Historically, we monitored the elution times of the
radioactive compounds by collecting 1-ml fractions and
then scintillation counting 1 ll from each fraction in 10
ml of water. An improvement has been implemented at this
stage; we now have an in-line radioactivity detector
attached to the HPLC. Therefore, we can now collect only
the NAADP peak (see Fig. 5B later). This minimizes radi-
ation exposure during the collection, because the fraction
collection tray does not need to be moved for each 1-ml
sample, but only for the NAADP elution. Typically, the
NAADP is collected in two 1.5-ml microcentrifuge tubes.
The peak before the [32P]NAADP is [32P]NAAD (nicotinic
acid adenine dinucleotide) (Fig. 3B), synthesized by base
exchange of nicotinic acid with the nicotinamide on
NAD that was not phosphorylated. This [32P]NAAD is
the major product in some syntheses if the phosphorylation
does not proceed to completion. The small peak after the
[32P]NAADP is [32P]ADPR-P (Fig. 3B) resulting from the
base exchange reaction when water is the attacking nucle-
ophile. A very detailed account of this procedure can befound in Morgan and coworkers’ study [18]. A less satisfac-
tory alternative, albeit one that requires less equipment and
hence may be considered more ﬁnancially viable, is to use
the [32P]NAADP without further puriﬁcation.
Determination of sample concentrations using a binding
curve
To begin the radioreceptor binding assay, a range of
known concentrations of unlabeled NAADP are added
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Fig. 6. Improvement of NAADP detection in cell extract samples. The
green trace shows standards made in intracellular medium (Glu-IM), the
blue trace shows standards in ‘‘acid-extracted’’ intracellular medium, and
the red trace shows standards in intracellular medium supplemented with 1
M potassium acetate. Error bars represent standard errors of the mean (n
= 3). (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the Web version of this article.)
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ing the binding protein for NAADP, is then added. Sam-
ples are incubated for 10 min to allow NAADP to bind
irreversibly to its receptor. [32P]NAADP is then added,
and samples are incubated for a further 10 min to allow
[32P]NAADP to bind to the remaining free binding pro-
tein. Samples are then ﬁltered using a cell harvester. Pro-
tein is retained on the ﬁlter paper; hence, the total
radioactivity bound may be determined (Fig. 1B). Sample
concentrations may then be determined from the standard
curve.
To demonstrate that changes in NAADP in cell samples
are detected using this method, a cell extract was per-
formed from mouse pancreatic acinar cells. This was then
serially diluted to produce a range of more dilute samples.
Changes in NAADP were correctly detected from the stan-
dard curve (Fig. 4). That is, a given fold dilution resulted in
the expected fold change in the NAADP detected.
Inhibition of binding using related nucleotides and other
Ca2+-releasing messengers
As with all binding assays, a potential problem is selec-
tivity, that is, displacement of [32P]NAADP by compounds
other than NAADP in the test samples. To examine the
extent of this possible problem, we screened several struc-
turally related compounds to establish their relative ability
to displace NAADP binding. The full concentration–dis-
placement curves are shown in the supplementary data
(see Supplementary Fig. 2). As expected, several com-
pounds compete when present at high enough concentra-
tions. The results can be summarized by the IC50 values
from the assay as follows: NAADP (540 pM), NADP (21
lM), NADPH (6.3 lM), cADPR (2.5 lM), and NAAD
(51 lM). Other compounds failed to displace NAADP at
the maximum concentrations tested in the assay: ATP
(100 lM), ADP (100 lM), AMP (100 lM), NAD (2
mM), NADH (2 mM), ADPR (100 lM), IP3 (100 lM),
and nicotinic acid (100 lM). These results are based on
commercially obtained compounds (except cADPR, which
was synthesized in-house, and NADP, which underwent
puriﬁcation by HPLC). We interpreted these results by not-
ing that all samples result from dilute cell suspensions and
are further diluted at least 100-fold in the ﬁnal assay, and
then we calculated the maximum NAADP displacement
based on known cellular concentrations of the metabolites.
We concluded that none of these compounds presented any
worries with regard to interference in the binding assay.
For example, ATP has an intracellular concentration of
between 1 and 5 mM [31] and would be present in the assay
at a maximum of 200 nM; therefore, it would not displace
NAADP.
Validity of assay under cell extract conditions
Although none of the potential inhibitors of NAADP
binding tested is able to displace NAADP at the concentra-tions present in a cell extract, it remains a possibility that
the combination of these various compounds present in
the cell would be able to displace NAADP and, hence,
interfere with the assay. To test this possibility, a sample
of chopped rat brain (McIlwain tissue chopper, 650 lm,
from 250- to 300-g female Wistar rat) was processed by
acid extraction in the manner described in Materials and
Methods. This was then spiked with two known 10-fold
diﬀerent concentrations of NAADP. The NAADP in these
samples was then analyzed using the radioreceptor binding
assay (Fig. 5). The NAADP concentrations determined
were 10-fold diﬀerent, as expected, demonstrating that
changes in NAADP are accurately detected under cell
extract conditions. Endogenous NAADP prevents precise
detection of the original concentrations in this system.Improvement of sample detection
Initially, standard NAADP concentrations were made
up in intracellular medium because this provides suitable
conditions for the sea urchin egg homogenate and produces
reliable binding curves. However, it was often observed
that more radioactivity bound in tubes containing cell
extract samples than in the NAADP-free (i.e., intracellular
medium-only) standard. Therefore, we decided to make up
NAADP in a solution closer to the conditions prevalent in
the acid-extracted cell samples. Intracellular medium was
mixed with an equal volume of 1.5 M HClO4, and this solu-
tion was then mixed with an equal volume of 2 M KHCO3.
The resulting solution was centrifuged to remove the pre-
cipitate and then was used to dilute NAADP standard
for use in the assay (Fig. 6). The resulting displacement
curve has an identical IC50 and hill slope to that produced
with standards in intracellular medium, but the maximum
radioactivity bound increased by approximately threefold.
Based on previous reports [23], we hypothesised that the
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eﬀect. Therefore, intracellular medium was supplemented
with an approximately equivalent concentration of K+ in
the form of an additional 1 M potassium acetate (pH main-
tained at 7.4). The binding assay was then repeated with
NAADP standards made up in this medium (Fig. 6). The
curve produced again had an identical IC50 and hill slope,
but with a threefold increase in maximum binding. Thus, it
is important to use NAADP standards in a buﬀer with the
same K+ concentration as the samples to maximize detec-
tion, particularly of very small NAADP concentrations.
Use of storage phosphor screen in place of scintillation
counting
We now describe a number of modiﬁcations to the pro-
cedure. These modiﬁcations aim to reduce exposure to
radioactivity, enhance detection of NAADP (particularly
in response to agonist stimulation), and enable samples
to be analyzed as expediently as possible. Traditionally,
radioactivity has been detected using Cerenkov scintillation
counting. This method may be used for counting the radio-
activity trapped on the ﬁlter papers in this assay, and it
produces accurate results. However, there are a number
of disadvantages to using this technique. Each circle of ﬁl-
ter paper must be transferred to an individual vial contain-
ing scintillation ﬂuid, and this is a laborious and time-
consuming process. Furthermore, disposal of these vials
and the scintillation ﬂuid generates a large volume of waste
and further exposure to radiation. Therefore, we have
adopted a diﬀerent technique for determining radioactivity
in our samples. Whole ﬁlter papers (containing 48 samples
with our harvester) are wrapped in cling ﬁlm and then
exposed to a storage phosphor screen for 1 to 4 h (depend-
ing on the activity of the [32P]NAADP). One screen is able
to expose to four such ﬁlter papers at a time; the times
given are suggested minima as the radioactivity decays,
but accurate readings may be obtained even after much
longer (e.g., overnight) exposures. The storage phosphor
screen stores a record of the sample. The screen is then
scanned using a Typhoon scanner at a wavelength of 633
nm. As this occurs, blue light (390 nm) is emitted and
detected by the scanner. The light intensity is directly pro-
portional to the radioactivity in the sample; in the images,
darker pixels relate to a higher light intensity (Fig. 7B).
To conﬁrm that the storage phosphor screen is able to
detect the radioactivity in samples over a suitable dynamic
range, and to demonstrate that the number of counts could
be determined when required, a range of dilutions of
[32P]NAADP were spotted onto ﬁlter papers. These were
analyzed ﬁrst by Typhoon scanning and second by scintil-
lation counting (Fig. 7A). This conﬁrmed that a storage
phosphor screen and Typhoon scanning may be accurately
used to determine radioactivity in a sample and that it can
be calibrated to determine the counts per minute if this
information is required. Furthermore, the radioactivity
on a ﬁlter paper produced in the NAADP radioreceptorbinding assay was determined using both techniques (Figs.
7B and 7C). The standard curves generated are identical,
further validating the use of this method.Measurement of NAADP accumulation over time in agonist-
stimulated cells: A novel methodology
The changes in NAADP levels reported heretofore in
mammalian systems consist of a sharp transient early spike
in NAADP levels [15], which is easy to miss, especially in
an uncharacterized system, depending on the time points
chosen. However, NAADP is believed to be metabolized
by a 2 0-phosphatase that is Ca2+ dependent [32]. Therefore,
we tested whether the breakdown of NAADP could be
inhibited by prior incubation of cells with the cell-permeant
form of the Ca2+ chelator BAPTA, BAPTA-AM (Fig. 8).
Incubation with BAPTA-AM alone produced no change
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Fig. 8. BAPTA-AM, a cell-permeant form of the Ca2+ chelator BAPTA,
prevents NAADP metabolism and, hence, facilitates NAADP measure-
ments in pancreatic acinar cells. The red trace shows cells preincubated
with 20 lM BAPTA-AM, followed by the addition of control buﬀer and
incubations for the various times. The blue trace shows cells that were
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response to CCK in the absence of BAPTA. This response is very transient
and, hence, diﬃcult to detect. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the Web version of this
article.)
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duced a continuous increase in NAADP levels that lasted
for at least 20 min. Thus, it is possible to detect changes
in NAADP in this system by measuring a basal level and
then accumulation over time after exposure to agonist.
This removes the potential problems of missing a transient
increase in NAADP levels because any NAADP synthe-
sized will not be broken down and will remain in the cells
for measurement. Thus, the detection of agonists that pro-
duce increases in NAADP levels is greatly facilitated, and
the problem of ‘‘false negatives’’ is nearly eliminated.
A similar technique has also proved to be useful in mea-
suring changes in the levels of second messengers. For
example, metabolism of cAMP may be prevented by the
application of methylxanthines [7]. Similarly, changes in
IP3 may be measured using a radioreceptor binding assay
[33]. However, in many systems, including pancreatic aci-
nar cells, the changes are transient and diﬃcult to detect.
Therefore, Li+ is routinely added to the cells to inhibit
metabolism of IP3 and, thus, allow measurement of accu-
mulation over time [34].
In conclusion, we have reported and validated a
method that allows rapid and accurate measurements of
NAADP concentrations. Information was provided in
suﬃcient detail to make the measurement of NAADP
accessible to a wider range of laboratories as the ﬁeld
grows. The acid extraction technique discussed is applica-
ble to a wide variety of systems; it may be used in cellcultures, isolated cells, chopped tissue, and indeed whole
tissue. The radioreceptor binding assay employed is highly
selective for NAADP and is suﬃciently sensitive to detect
very small concentrations of NAADP. Finally, and most
important, we reported a number of improvements to
the assay. In particular, the synthesis of [32P]NAADP
was modiﬁed to produce a very high yield with minimal
exposure. Furthermore, the detection of radioactivity in
samples is now faster, involves less exposure, and pro-
duces less waste. In addition, we developed a method to
prevent the metabolism of NAADP. This allows the mea-
surement of NAADP accumulation over time, giving
more straightforward detection of stimulus-induced
increases in NAADP. This development should prove to
be very useful in further investigations of the roles of
NAADP as a second messenger, just as it has been in
the IP3 ﬁeld, and should pave the way for simpler, more
sensitive determinations of changes in NAADP levels.
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